Nantahala Capital Management’s Apollo Endosurgery, Inc. APEN Stock Holding History

Nantahala Capital Management’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,000,000	Closed	-$19.8M	–	144
2023 Q1	$19.8M	Hold	2,000,000	–	–	1.52%	17
2022 Q4	$19.9M	Hold	2,000,000	–	–	1.29%	20
2022 Q3	$11M	Buy	2,000,000 +400,000	+25%	+$2.22M	0.71%	38
2022 Q2	$5.84M	Buy	+1,600,000	New	+$7.56M	0.29%	59

Nantahala Capital Management's APEN Position: Q2 2023 in Review

Nantahala Capital Management sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 4,575,021 shares — an estimated $45.4M sold.

Nantahala Capital Management first reported a position in APEN in Q2 2018 and held it in 20 quarters. The position peaked at $45.4M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Nantahala Capital Management reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Nantahala Capital Management sold 4,575,021 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $45.4M.
Nantahala Capital Management first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 20 quarters.
Nantahala Capital Management's Apollo Endosurgery, Inc. position peaked at $45.4M in Q1 2023.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Nantahala Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.